Pilot Study of Raltegravir Switch to Resolve Tenofovir Induced Proteinuria
NCT01044771
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
HIV Infections
Proteinuria
Interventions
DRUG:
change from tenofovir to raltegravir
Sponsor
Metropolis Medical
Collaborators
[object Object]